Botanical health products, positioning and requirements for effective and safe use

被引:37
作者
Bast, A
Chandler, RF
Choy, PC
Delmulle, LM
Gruenwald, J
Halkes, SBA
Keller, K
Koeman, JH
Peters, P
Przyrembel, H
de Ree, EM
Renwick, AG
Vermeer, ITM
机构
[1] Univ Maastricht, Dept Pharmacol & Toxicol, Maastricht, Netherlands
[2] Chandler Herbal Consulting, Halifax, NS, Canada
[3] Univ Manitoba, Fac Med, Winnipeg, MB, Canada
[4] Naredi, Brussels, Belgium
[5] Phytopharm Consulting, Berlin, Germany
[6] Univ Utrecht, Fac Pharmaceut Sci, Dept Med Chem, Utrecht, Netherlands
[7] Fed Inst Drugs & Med Devices, Bonn, Germany
[8] Inspectorate Hlth Protect & Vet Publ Hlth, The Hague, Netherlands
[9] Fed Inst Hlth Protect Consumers & Vet med, Berlin, Germany
[10] Numico Res, Wageningen, Netherlands
[11] Univ Southampton, Clin Pharmacol Grp, Southampton, Hants, England
关键词
botanical health product; herbal medicinal product; quality; efficacy and safety assessment of botanical products; procedure to categorize botanical products;
D O I
10.1016/S1382-6689(02)00035-2
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Within the group of botanical products there is a large range of variation with regard to their properties. Some products are identical to foods while others come close to or are medicines. Botanical products are regulated differently within the different member states of the European Union (EU) and globally. They are regulated either as food or as medicinal products, and in the latter case often with simplified registration procedures. These differences are caused by differences in traditional use, in cultural and historical background, in scientific substantiation and in enforcement of current legislation. One may expect that in the future differences will remain, unless EU legislation is enacted with sufficient room for different approaches. The strengths and weaknesses of the different regulatory procedures have been reviewed and evaluated as well as the current methods for quality, efficacy and safety evaluation. Criteria to categorize botanical products have been defined, such that botanical products can be regulated under the current food and medicinal regulations. Furthermore, a decision tree has been developed as a tool to distinguish herbal medicinal products from botanical health products and vice versa, and to provide a stepwise framework for the assessment of safety and efficacy. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 211
页数:17
相关论文
共 62 条
[1]  
*AESGP, 1998, HERB MED PROD EUR UN, P1
[2]   CONSUMPTION OF A GARLIC CLOVE A DAY COULD BE BENEFICIAL IN PREVENTING THROMBOSIS [J].
ALI, M ;
THOMSON, M .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 53 (03) :211-212
[3]  
[Anonymous], 2000, HERBAL MED EXPANDED
[4]  
[Anonymous], 2001, FOOD HIST
[5]  
[Anonymous], [No title captured]
[6]  
[Anonymous], 1987, PRINC SAF ASS FOOD A
[7]  
[Anonymous], 1999, WHO MONOGRAPHS SELEC
[8]  
Bayne CW, 1999, PROSTATE, V40, P232, DOI 10.1002/(SICI)1097-0045(19990901)40:4<232::AID-PROS4>3.0.CO
[9]  
2-0
[10]  
*BELG STAATSBL, 1997, KON BESL 29 AUG 1997